32
Total investments
21
Early stage
1
Mid stage
1
Late stage
66y
Years active
Portfolio
26 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Angel Investor (Board Observer)
Sep 2022
Avisi is a medical devices startup investigating the use of patented nanotechnology in an ocular implant to stop blindness in glaucoma patients.
Glaucoma is the second leading cause of blindness in the world and currently has no cure.
To date, Avisi has been supported by grants and awards from: the National Science Foundation, Ben Franklin Technology Partners, the University of Pennsylvania, Wharton, The School of Engineering and Applied Science, Venture Initiation Program Accelerator (VIP-X), Penn Law's Entrepreneurship Legal Clinic, VentureWell E-Teams, and Ballard Spahr BASE.
Avisi is a proud member of Johnson & Johnson JLABS incubator, UCSF Rosenman Innovators, OC OCTANE LaunchPad, and MedTech Innovator Accelerator.
Twitter: @avisi_tech
Website: www.avisitech.com
Angel Investor (Board Member)
Jan 2013
New York Angels is a member-led organization committed to finding, funding and mentoring great young companies from pitch through successful exit. Our 120+ members are entrepreneurs, CEOs, venture capitalists and business leaders who have founded, funded and built world-class companies. We come from a wide array of industry backgrounds and together create an extensive network of entrepreneurial support. We mentor and coach the entrepreneurs in whom we invest, serve on their boards, provide contacts and assist with team building, strategic planning and fundraising.
The mission of New York Angels is to foster an engaged and smart New York City angel investment environment in an effort to enhance the opportunities for entrepreneurs to be financed and succeed through exit. We provide opportunities for our members to obtain outstanding financial returns by investing in early-stage companies and accelerating them to market leadership. We lead and participate in investments ranging from $100,000–$2,000,000, and have a large network of angel groups and venture capital firms with whom we syndicate to do rounds up to $3 million.
New York Angels has been the leading seed investment organization in NYC since 2004, with members investing over $112 million into more than 270 exciting startup companies. Through their participation in New York Angels, members were the first investors in such startups as Pinterest and Comixology, and portfolio companies have been acquired by Google, Intel, CBS, Living Social and others.
Non-Profit Startup Investor (failed)
2010
We connect individuals to organizations working to change the world.
Angel Investor (many failures, M&As, and IPOs)
1997
Bill Gross started Idealab in 1996 to create and operate pioneering technology companies. The structure of Idealab has allowed us to test many ideas at once and turn the best of them into companies, attracting the human and financial capital necessary to bring them to market.
Many of these companies were among the first to introduce new business ideas to the market. CitySearch, now a part of IAC, established the category of local online community directories. eToys demonstrated the tremendous potential for online consumer retail and became one of the most recognized brands during the early days of e-commerce. Overture Services, which began life as GoTo.com, was the first company to introduce the concept of paid search — the business model that powers the multibillion-dollar online search market.
Idealab continues to explore a range of technology frontiers. New models for improving the search experience are at the core of several companies currently growing inside of Idealab. Moving beyond the Internet, we have spawned companies with breakthrough technologies in robotics, renewable energy and automotive design and production among others. Idealab also continues to partner with leading venture capital firms and other strategic investors to provide the resources to maximize the potential of these companies.
In addition to capital, Idealab provides a full range of resources to infuse start-ups with the support they need to rapidly introduce innovative products and services. Resources include office space and the accompanying office services, development and technology, product and graphic design, marketing, financial advice, human resources, competitive research, legal, accounting and business development support and services. In addition, Idealab provides advice on strategy, branding and corporate structure.
Angel Investor (acquired by Tandem)
Jan 1962
Capillary Biomedical, Inc. (CapBio) is a medical device startup developing technologies for diabetes management. We aim to dramatically simplify insulin delivery, reducing the burden on both patients and the overall healthcare system.
CapBios first product is the patent-pending SteadiSet infusion set for insulin pump therapy. Its SteadiFlow technology features a kink-proof, super-soft cannula with multi-port delivery designed for reliable and comfortable insulin delivery. Our user-friendly insertion device makes it easy.
The company is based in Irvine, CA and is a spin-out of the Artificial Pancreas Center at the Sidney Kimmel Medical College of Thomas Jefferson University in Philadelphia, PA. This ongoing academic-industry collaboration is focused on improving the comfort, reliability and predictability of insulin infusion therapy. Together, we aim to achieve more consistent and reliable insulin absorption, which will enable people with diabetes to achieve improved blood glucose control.
Angel Investor
Jan 1960
Turn a property into income. Taking the first step is hard. Doing it right is even harder. For both newcomers and seasoned pros, Futurestay makes it easy to earn money in the short-term rental industry.
Futurestay's business dashboard controls a property everywhere, from Airbnb, Vrbo and Booking.com, to their own branded website with a direct booking engine.
Angel Investor
Jan 1960
CrowdTangle is a content discovery tool for the social web. It is easiest way to follow whats happening on Facebook. Currently, in private beta please go to our website (www.crowdtangle.com) to request an invite.
Join the CrowdTangle! We are a small team with a strong set of values that guide our work and we are growing quickly. This is a unique chance to get in on the ground floor.
Angel Investor
Jan 1960
Runthrough is the Fashion Industry’s first super network.
Runthrough amplifies relationships in the fashion industry by combining the connectivity of a social network with the functionality of content management and business workflow tools. Our B2B SaaS platform is transforming the way brands and editors communicate, share, and connect on products and content.
Angel Investor (Board Observer)
Jan 1960
Xola provides cloud-based software that makes it simple for businesses to manage reservations in real time from any channel—bookings made in-person, over the phone, through their company website, on Xola’s vendor mobile app, with local resellers, and online travel agents that are integrated with Xola.
The tours and activities landscape is incredibly fragmented, comprised largely of SMBs with limited access to modern business tools. As a result, these companies suffer from operational deficiencies and often fall short of their economic potential. Not only is this a problem for local providers but also for tour resellers like Viator, Groupon, Kayak and others.
Xola’s reservation software fills this vital distribution gap and helps tour operators accelerate their growth with its cloud-based and easy-to-use tools. The tours and activities industry is worth $120 billion globally, and with Xola, tour providers and resellers can tap into this immense market unlike ever before.
Were not the only ones that recognize the importance of powerful software in this industry. Stephen Ambrose of Steadfast Venture Capital argues that in travel technology, “the back end is really the emerging opportunity... One reason it is exciting is that it is not crowded, not noisy.”
Xola is growing quickly and is looking for top performers to help us serve the business needs of tens of thousands of tour and activity companies worldwide.
Angel Investor (Board Observer & largest investor)(acquired by Medtronic)
Jan 1960
Our team of nutrition enthusiasts, engineers and data scientists are united by one singular goal: to provide personalized nutritional insights to every person on earth, empowering humankind to live smarter, healthier, and happier.
...
Today’s food culture is a whirlwind of diets, fads and confusing information. Is gluten bad for us, or is it necessary for a healthy diet? Should we stop eating meat, or do we need those nutrients? Does coffee cause cancer, or help prevent it?
Every day, we’re bombarded by contradictory messages like these. It’s time for a change. Nutrino places transformative nutritional insights in the hands of people worldwide — giving them smart, personalized analyses of how their bodies interact with the foods they eat.
Nutrino continually collects a wealth of food, sleep, health and activity data from people like you, through wearables and other technologies like image recognition. Its cutting-edge AI cross-references this data with nutritional values from the world’s largest food database, to deliver real-time individual insights on what’s best for your body.
These FoodPrints™ tell you exactly how your body reacts to food. For example, when you and a friend both eat an apple, your body will respond in unique ways, storing the nutrients influencing your energy and mood according to factors as unique as you are. FoodPrints™ are as one-of-a-kind as your fingerprints — and they help you make smarter food decisions in real time.
The dark ages of vague predictions and health warnings are over. Nutrino integrates with a host of powerful technologies — from apps to wearables to large-scale healthcare management systems — to empower people around the world to understand exactly how their bodies interact with every meal and snack they eat.
We all love food — and now we can discover which foods love us back.
Angel Investor
Jan 1960
Thrive Bioscience’s instruments and software provide automated imaging and analytics of live cells and tissues for research and drug discovery. Thrive instruments automatically build extensive databases of terabytes of time-series images at 100 focal planes of all the cells in all the wells in cell culture plates.
Angel Investor
Jan 1960
Physician-first Care & Guidance. Where the point of care meets the moment of need. Virtual care solutions that deliver immediate, affordable, high quality care to improve health and reduce costs.
Angel Investor
Jan 1960
Xola provides cloud-based software that makes it simple for businesses to manage reservations in real time from any channel—bookings made in-person, over the phone, through their company website, on Xola’s vendor mobile app, with local resellers, and online travel agents that are integrated with Xola.
The tours and activities landscape is incredibly fragmented, comprised largely of SMBs with limited access to modern business tools. As a result, these companies suffer from operational deficiencies and often fall short of their economic potential. Not only is this a problem for local providers but also for tour resellers like Viator, Groupon, Kayak and others.
Xola’s reservation software fills this vital distribution gap and helps tour operators accelerate their growth with its cloud-based and easy-to-use tools. The tours and activities industry is worth $120 billion globally, and with Xola, tour providers and resellers can tap into this immense market unlike ever before.
Were not the only ones that recognize the importance of powerful software in this industry. Stephen Ambrose of Steadfast Venture Capital argues that in travel technology, “the back end is really the emerging opportunity... One reason it is exciting is that it is not crowded, not noisy.”
Xola is growing quickly and is looking for top performers to help us serve the business needs of tens of thousands of tour and activity companies worldwide.
Angel Investor
Jan 1960
Safer, more efficient and enjoyable driving experience, anywhere, anytime – with tactile data.
Feeling the tactility (i.e. dynamics) that is created between a vehicle and the road is key for optimizing safety, user experience, and efficiency, either if a person or a computer drives a vehicle. Tactile Mobility provides smart and autonomous vehicles (AVs) with the missing tactile sensing and data that makes vehicles smarter, roads better, and mobility-ecosystems enhanced.
Solutions
Our tactility-sensing innovation empowers multiple data solutions that maximize safety, user-experience, and driving efficiency in the mobility industry. Already crunched +10,000,000 km, and analyzed +100,000 trips, Tactile Mobility’s platform offers the following value propositions:
- For OEMs - Benefit from the new industry standard in vehicle data. Through our software licensing and data services, OEMs leverage a unique system empowering them to give smart and autonomous vehicles the tactile capacity that augments vision and auditory sensing. The missing sense delivered by Tactile Mobility is central for both smart vehicles (ADAS / level 2-3 AVs) and autonomous vehicles (level 4-5 AVs) alike.
- For mapping companies, road authorities, transport associations, insurers - Benefit from our cloud-based analytics that generates a SurfaceDNA HD map layer of great accuracy and coverage, outlining roadway grades, banking, curvature, and any hazards such as bumps, cracks, and potholes. This level of information is immensely valuable for planned maintenance, real-time hazard detection, post-accident analysis, and more.
- For fleet managers, car manufacturers, part suppliers - Benefit from our hardware and web tool, offering vital information for optimizing fuel consumption, fuel theft detection, route pricing, and preventive maintenance based on our innovative SurfaceDNA and VehicleDNA data models.
For more information go to www.tactilemobility.com or e-mail us at info@tactilemobility.com.
Angel Investor
Jan 1960
PainQx is a Philadelphia based startup that has developed a way of objectively measuring pain in humans. PainQx is able to accomplish this by reading EEG waves from a patient's brain and running the data through it’s proprietary algorithm to produce a pain score consistent with the VAS System. The PainQx system is currently being used as a clinical assessment tool in the research market for use as a scaled pain biomarker and placebo responder screen.
Strong IP Position
Proven results in human clinical setting
Experienced scientific team
Confirms the actual level of acute pain in patients
Guides appropriate treatment to avoid the over or under prescription of analgesics
Measures pain patient populations that cannot accurately articulate or express pain
Show all 26 investments ↓
Experience · 33 entries
All (33)
Investments (32)
Founder (1)
Board (6)
2022
Angel Investor (Board Observer)
Sep 2022
Avisi is a medical devices startup investigating the use of patented nanotechnology in an ocular implant to stop blindness in glaucoma patients.
Glaucoma is the second leading cause of blindness in the world and currently has no cure.
To date, Avisi has been supported by grants and awards from: the National Science Foundation, Ben Franklin Technology Partners, the University of Pennsylvania, Wharton, The School of Engineering and Applied Science, Venture Initiation Program Accelerator (VIP-X), Penn Law's Entrepreneurship Legal Clinic, VentureWell E-Teams, and Ballard Spahr BASE.
Avisi is a proud member of Johnson & Johnson JLABS incubator, UCSF Rosenman Innovators, OC OCTANE LaunchPad, and MedTech Innovator Accelerator.
Twitter: @avisi_tech
Website: www.avisitech.com
2013
Angel Investor (Board Member)
Jan 2013
New York Angels is a member-led organization committed to finding, funding and mentoring great young companies from pitch through successful exit. Our 120+ members are entrepreneurs, CEOs, venture capitalists and business leaders who have founded, funded and built world-class companies. We come from a wide array of industry backgrounds and together create an extensive network of entrepreneurial support. We mentor and coach the entrepreneurs in whom we invest, serve on their boards, provide contacts and assist with team building, strategic planning and fundraising.
The mission of New York Angels is to foster an engaged and smart New York City angel investment environment in an effort to enhance the opportunities for entrepreneurs to be financed and succeed through exit. We provide opportunities for our members to obtain outstanding financial returns by investing in early-stage companies and accelerating them to market leadership. We lead and participate in investments ranging from $100,000–$2,000,000, and have a large network of angel groups and venture capital firms with whom we syndicate to do rounds up to $3 million.
New York Angels has been the leading seed investment organization in NYC since 2004, with members investing over $112 million into more than 270 exciting startup companies. Through their participation in New York Angels, members were the first investors in such startups as Pinterest and Comixology, and portfolio companies have been acquired by Google, Intel, CBS, Living Social and others.
2010
Non-Profit Startup Investor (failed)
2010
We connect individuals to organizations working to change the world.
J
Jumo (failed)
Non-Profit Startup Investor
2010
1997
Angel Investor (many failures, M&As, and IPOs)
1997
Bill Gross started Idealab in 1996 to create and operate pioneering technology companies. The structure of Idealab has allowed us to test many ideas at once and turn the best of them into companies, attracting the human and financial capital necessary to bring them to market.
Many of these companies were among the first to introduce new business ideas to the market. CitySearch, now a part of IAC, established the category of local online community directories. eToys demonstrated the tremendous potential for online consumer retail and became one of the most recognized brands during the early days of e-commerce. Overture Services, which began life as GoTo.com, was the first company to introduce the concept of paid search — the business model that powers the multibillion-dollar online search market.
Idealab continues to explore a range of technology frontiers. New models for improving the search experience are at the core of several companies currently growing inside of Idealab. Moving beyond the Internet, we have spawned companies with breakthrough technologies in robotics, renewable energy and automotive design and production among others. Idealab also continues to partner with leading venture capital firms and other strategic investors to provide the resources to maximize the potential of these companies.
In addition to capital, Idealab provides a full range of resources to infuse start-ups with the support they need to rapidly introduce innovative products and services. Resources include office space and the accompanying office services, development and technology, product and graphic design, marketing, financial advice, human resources, competitive research, legal, accounting and business development support and services. In addition, Idealab provides advice on strategy, branding and corporate structure.
Show all 33 entries ↓
Investment activity
1960–2022 · 32 investments
Recent (last 2 years)Earlier
